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Abstract
Background: A rare disease is a pattern of symptoms that afflicts less than five in 10,000 patients. However, as
about 6,000 different rare disease patterns exist, they still have significant epidemiological relevance. We focus on
rare diseases that affect multiple organs and thus demand that multidisciplinary healthcare professionals (HCPs)
work together. In this context, standardized healthcare processes and concepts are mainly lacking, and a deficit of
knowledge induces uncertainty and ambiguity. As such, individualized solutions for each patient are needed. This
necessitates an intensive level of innovative individual behavior and thus, adequate idea generation. The final
implementation of new healthcare concepts requires the integration of the expertise of all healthcare team
members, including that of the patients. Therefore, knowledge sharing between HCPs and shared decision making
between HCPs and patients are important. The objective of this study is to assess the contribution of shared
communication and decision-making processes in patient-centered healthcare teams to the generation of
innovative concepts and consequently to improvements in patient satisfaction.
Methods: A theoretical framework covering interaction processes and explorative outcomes, and using patient
satisfaction as a measure for operational performance, was developed based on healthcare management,
innovation, and social science literature. This theoretical framework forms the basis for a three-phase, mixed-
method study. Exploratory phase I will first involve collecting qualitative data to detect central interaction barriers
within healthcare teams. The results are related back to theory, and testable hypotheses will be derived. Phase II
then comprises the testing of hypotheses through a quantitative survey of patients and their HCPs in six different
rare disease patterns. For each of the six diseases, the sample should comprise an average of 30 patients with six
HCP per patient-centered healthcare team. Finally, in phase III, qualitative data will be generated via semi-
structured telephone interviews with patients to gain a deeper understanding of the communication processes
and initiatives that generate innovative solutions.
Discussion: The findings of this proposed study will help to elucidate the necessity of individualized innovative
solutions for patients with rare diseases. Therefore, this study will pinpoint the primary interaction and
communication processes in multidisciplinary teams, as well as the required interplay between exploratory
outcomes and operational performance. Hence, this study will provide healthcare institutions and HCPs with results
and information essential for elaborating and implementing individual care solutions through the establishment of
appropriate interaction and communication structures and processes within patient-centered healthcare teams.
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Rare diseases are defined as specific disease patterns with a
prevalence of less than five in 10,000 [1] patients. This
infrequent prevalence causes a serious deficit of expert
knowledge that often induces uncertainty, ambiguity, and
unpredictability in routine care. However, patients with
rare diseases frequently have a strong need for complex
and multidisciplinary treatment. Expertise and knowledge
are required, but they are often located in dispersed cen-
ters of expertise, and are thus disconnected from the local
healthcare environment of patients. Standardized health-
care guidelines are lacking due to the great variance of
symptoms and treatment processes within each disease
pattern. Therefore, multidisciplinary healthcare teams,
diverse in education and function, are tasked with creating
new, individual, patient-centered solutions to improving
patients’ long-term healthcare situation. We define this
necessary innovative behavior of healthcare providers
(HCPs) as the intensity of proactive behavior and improvi-
sation to find adequate individualized solutions for each
patient and to implement new processes, products, or pro-
cedures to enhance medical outcomes. In addition to the
emerging incremental adaptations of current healthcare
processes, initiatives and new solutions for medical pro-
ducts and procedures arise that have to be transferred to
other HCPs. To cope with the complexity of rare diseases,
idea generation and implementation both require the inte-
gration all team members’ expertise, including that of the
patient. As such, communication processes between the
involved actors play an essential role. Our study focuses
on two different communication processes, knowledge
sharing between HCPs and shared decision making
between HCPs and patients. Based on two different litera-
ture streams, innovation management and health service
research, we suggest that both communication processes
will foster HCPs’ innovative behavior, which in turn influ-
ences patient satisfaction positively (see Figure 1). These
communication processes are influenced by specific
characteristics of rare diseases. In particular, HCPs and
patients have to deal with the high functional diversity of
the team [2-4] and high environmental uncertainty that
affect routine and explorative processes [5,6]. In this study,
we develop a theoretical framework and derive hypotheses,
as indicated in the study framework above. We also
describe the study plan and discuss central contributions
of this study.
In this study, we develop a theoretical framework and
derive hypotheses, as indicated in the study framework
above. We also describe the study plan and discuss cen-
tral contributions of this study.
Knowledge sharing and its influence on innovative
behavior and patient satisfaction
We define innovative behavior as the introduction and
implementation of new ideas, processes, products, or
procedures designed to significantly benefit the patient.
Several authors see knowledge as a critical resource of
organizations, networks, or teams that provides a sus-
tainable advantage for innovative performance outcomes
[7-9]. This assertion is applicable to knowledge-intense
working contexts where information is broadly lacking -
the treatment of patients with rare diseases. Knowledge,
defined as ‘a fluid mix of framed experience, values,
contextual information, and expert insights [...]’ [8],
represents the basis for evaluating and incorporating
new experiences and information to create new health-
care concepts and treatments fitting patients’ needs [8].
Different HCPs carry different expertise. Therefore,
diverse teams possess a broader range of explicit knowl-
edge and a larger pool of abilities and skills, and thereby
may lead to improved patient outcomes [2,10]. The vari-
ety of knowledge carriers underlies the importance of
knowledge-sharing processes between members of
healthcare teams. If knowledge is not shared, cognitive
resources available within a team remain idle [11].
Strong relationships and interactive knowledge sharing
enable the team to create new solutions [12,13] by com-
bining new with existing knowledge to come up with
novel ideas and concepts [14]. In our study, knowledge
sharing is considered to be an interactive communica-
tion process between at least two HCPs. It is character-
ized by various communication attributes, such as the
frequency and reciprocity of knowledge exchange, the
multiplicity of knowledge content [15], and the quality
and strength of the HCPs’ relationships [16]. Referring
to healthcare teams dealing with patients with rare dis-
eases, we assume that internalk n o w l e d g e - s h a r i n gp r o -
cesses start immediately after a multidisciplinary
healthcare team is assembled. This builds a foundation
for essential innovative healthcare activities. The meta-
analytic overview from van Wijk [17] supports this idea
by showing a significant overall correlation between
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Figure 1 Study framework.
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correlation underlines our assumption that within
healthcare teams, interactive knowledge-sharing pro-
cesses positively influence HCPs’ innovative behavior.
In addition to the need for knowledge sharing for
explorative outcomes, operational performance also
depends on the intensity of knowledge sharing between
HCPs, particularly specifick n o w l e d g er e l a t e dt om o r e
routine activities [17]. Knowledge sharing can also be
seen as an essential aspect of meeting patients’ needs in
the operational treatment of daily healthcare processes.
As such, we suggest that intensive information exchange
concerning the care of patients with rare diseases signifi-
cantly affects patient satisfaction by better fitting their
permanent needs.
Shared decision making and its influence on innovative
behavior and patient satisfaction
Although the concept of knowledge sharing focuses
mainly on HCPs, the interaction with the patient, and in
particular the process of shared decision making (SDM),
must also be addressed. SDM can be defined as an inter-
active process in which at least two participants - physi-
cian and patient - share information and equally reach an
agreement on the treatment to implement [18,19].
Despite the considerable challenges associated with deci-
sion making for rare diseases, investigations into the
shared decision-making process, its implications, and its
impact on innovative behavior in the setting of rare dis-
eases have been lacking. Moreover, outside of the health-
care context, researchers have typically studied
participation effects in the organizational context, focus-
ing for example on the leadership style and its impact on
employees’ innovativeness [20]. The influence of the
patient’s participation in decision making on the service
provider’s innovative behavior has received minimal
attention in the literature to date. Preliminary indications
have arisen from the literature review and Delphi study
by Fleuren [21]. They identified patient cooperation as a
relevant determinant of innovative behavior within
healthcare organizations. Especially in the context of rare
diseases characterized by uncertainty due to insufficient
knowledge, mutual willingness to influence and to be
influenced is essential for the development of creative
ideas and their transformation into workable methods,
products, and services. We argue that as the patient
becomes more involved in the decision-making process,
the solutions developed by HCPs may be re-examined
and re-evaluated [22]. Hence, it enables HCPs to critically
process their own creative ideas and to pursue those that
will best meet the patients’ expectations and require-
ments. We therefore state that there is solid justification
for exploring participation and particularly shared deci-
sion making as an important determinant of innovative
behavior of HCPs. Additionally, through fostering a com-
mon understanding of the disease between patient and
HCPs, patient involvement in treatment decisions may
help the HCPs to better meet the patient’s needs by pro-
viding customized healthcare [23]. The gap between the
patient’s expectations and their perception of perfor-
mance will diminish [24]. Thus, shared decision making
also has a positive effect on patient satisfaction.
Innovative behavior and its influence on patient
satisfaction
New medical products and processes require innovative
behavior from HCPs. This is of particular importance
for patients with rare diseases, because innovative con-
cepts must compensate for limited knowledge and miss-
ing routines. As a result, the healthcare team improves
its ability to serve and help patients [25]; the patient will
receive appropriate and highly suitable help, and will be
more satisfied. As such, we suggest that innovative
behavior positively relates to overall healthcare perfor-
mance and more specifically to patient satisfaction.
In conclusion, based on the above-mentioned assump-
tions, this study aims to test the following hypotheses
concerning the impact on patient satisfaction of knowl-
edge sharing and shared decision making mediated by
innovative behavior of individual HCPs operating under
uncertain conditions in multidisciplinary teams:
Hypothesis 1: Knowledge sharing between HCPs in
patient-centered teams positively influences innovative
behavior.
Hypothesis 2: Knowledge sharing between HCPs in
patient-centered teams has a direct positive influence on
patient satisfaction.
Hypothesis 3: Patient involvement in shared decision
making positively influences HCPs’ innovative behavior.
Hypothesis 4: Patient involvement in shared decision
making has a direct positive influence on patient
satisfaction.
Hypothesis 5: HCPs’ innovative behavior positively
influences patient satisfaction.
Methods
Design
The overall design is an empirical study in which a ser-
ies of attributes of individuals and teams are measured
to test the developed hypotheses. A three-phase, mixed-
method and multi-level study will be conducted. Phase I
is an exploratory study, phase II is the quantitative part
of the main study, and phase III is the qualitative part
of the main study.
Participants and sample size
Through expert interviews with various physicians spe-
cializing in the care of rare diseases and with
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wide range of disease patterns and finally focused the
study on six different rare diseases. They were selected
by pre-defined criteria: a requirement for multidisciplin-
ary team work, regionally dispersed expertise, limited
experience, a degree of uncertainty due to an absence of
knowledge and routines, and extraordinary individual
healthcare demands. We tried to choose diseases that
mainly differ in care intensity, level of suffering, patients’
age of disease outbreak (adults versus children), affected
organs, and prevalence. Thus, in an iterative process, we
finally chose the following diseases to test our theoreti-
cal framework: Amyotrophic lateral sclerosis, Marfan’s
syndrome, Wilson’s disease, Epidermolysis bullosa,
Duchenne muscular dystrophy, and Neurodegeneration
with brain iron accumulation.
Patients will be recruited via brochures placed in cen-
ters of expertise and specialized hospitals for rare dis-
eases as well as in non-profit self-help organizations. For
each of the six diseases, the sample should comprise 30
patients. Only patients and their HCPs whose perma-
nent residence is in Germany will be recruited. To shed
light on shared communication processes among health-
care teams, we will address several HCPs of each
patient-centered healthcare team. Patients who have
declared their participation will then be asked to return
a list indicating all members of their healthcare team.
On average, we expect six HCPs per patient-centered
healthcare team, e.g., general practitioners, nurses, heath
care aides, physicians in hospitals or ambulatory set-
tings, and various therapists and social workers involved
in operational healthcare processes. Out of our chosen
diseases, neurodegeneration with brain iron accumula-
tion has the smallest prevalence, with about 50 patients
in Germany. To ensure comparability we will send out
50 patients’ questionnaires for all the selected diseases
and expect a response rate of 60%. We anticipate that a
high number of patients will participate in our study
because they typically display a high level of personal
concern. Moreover, our exploratory pre-study in phase I
indicated that both patients and HCPs were enthusiastic
to participate. Therefore, we also expect a relatively high
response rate of 40% for the six HCPs per team. In
total, we expect to build on data from 180 patients and
432 HCPs.
Data collection
Phase I: exploratory pre-study
In an initial pre-study, we collected data via exploratory
interviews to detect central barriers teams have to cope
with in their daily work with patients suffering from
rare diseases. We collected data from four patient-cen-
tered healthcare teams, including four patients and rela-
tives together with 16 HCPs such as nurses, healthcare
givers, doctors, therapists, health insurance agents, and
service employees of medical device producers. In addi-
tion to resource restrictions, we mainly detected limita-
tions in communication processes between HCPs and
patients as well as between members of healthcare
teams. Therefore, our findings highlighted a significant
need for specific intra-team processes such as extensive
knowledge sharing and shared decision making within
healthcare teams including patients. Additionally, the
interviews confirmed the relevance of individualized
solutions to improving long-term healthcare and conse-
quently to increasing patient satisfaction.
Phase II: quantitative main study
The main study is a deductive analysis aiming to test
our hypotheses mentioned above - that knowledge shar-
ing and shared decision making positively influence
HCPs’ innovative behavior, which consequently leads to
better patient satisfaction. Questionnaires will be sent
out to our above-described sample evaluating demo-
graphic data, frequency, reciprocity and multiplexity of
knowledge sharing, the role of shared decision making
between patients and HCPs, individual innovative beha-
vior, and patient satisfaction. Together with the ques-
tionnaire, each patient will be asked to return a list
indicating their healthcare team members. In a second
step, we will send a questionnaire to each of the stated
healthcare team members evaluating demographic data,
functional diversity, environmental uncertainty, fre-
quency, reciprocity and multiplexity of knowledge shar-
ing, and individual innovative behavior.
Phase III: qualitative main study
After receiving the questionnaires, we will conduct
semi-structured telephone interviews with the patients.
The interviews will last approximately 20 minutes and
will be designed in accordance with recommendations
for qualitative research [26-28]. The objective of these
interviews is to gain a deeper understanding of the pro-
cesses of knowledge sharing and shared decision making
among healthcare team members and their initiatives to
find innovative solutions. By combining our qualitative
and quantitative results, we aim to formulate concrete
proposals on how to optimize communication and inno-
vation processes for rare diseases.
Measurement and analysis
All questionnaire items will be rated on a seven-point
Likert scale ranging from 1 ‘strongly disagree’ to 7
‘strongly agree.’ I nl i n ew i t ho u rs t u d yf r a m e w o r k ,w e
will examine the following four concepts: knowledge
sharing, shared decision making, HCPs’ innovative beha-
vior, and patient satisfaction. To examine knowledge
sharing within healthcare teams, every participant will
be asked to indicate how often (daily, weekly, monthly,
or less than once a month) he/she interacts with each
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information about healthcare procedures and processes)
and declarative knowledge (e.g. information about diag-
nosis, symptoms, or therapies). This means of measuring
knowledge sharing was adapted from Bakker et al. [15]
and will result in a matrix that captures the intensity of
knowledge sharing regarding procedural and declarative
information between members of each team. We will
use the nine-item Shared Decision-Making Question-
naire (SDM-Q-9) from Kriston et al. [19] to assess the
use of shared decision making within healthcare teams.
SDM is defined here as an interactive process in which
patients and their HCPs share information equally in
reaching an agreement on treatment. Hence, the ques-
tionnaire consists of nine items each describing one step
of the SDM process. A sample item is ‘My doctor
helped me understand all the information.’ Innovative
behavior will be measured with a scale combined from
two previously developed scales: the creativity scale of
Zhou and George [29] (three items, e.g., ‘I am/He/She is
ag o o ds o u r c eo fc r e a t i v ei d e a s ’) and the innovation
scale developed by Scott and Bruce [20] (two items, e.g.,
‘I/He/She promote(s) and champion(s) ideas to others.’).
We chose this combination of items because they repre-
sent the major stages in the individual innovative beha-
vior process (problem identification, information
searching and encoding, idea generation, and implemen-
tation) and because they are the most appropriate for
the given context of healthcare teams working on uncer-
tain tasks such as rare diseases. The innovative behavior
of each HCP will be measured using a two-informant
design via self-evaluation and external evaluation
through patients. To explore patient satisfaction, we will
use a patient satisfaction scale based on the Munich
Patient Satisfaction Scale (MPSS-24), which in its origi-
nal form consists of 24 items mainly addressing socio-
emotional and communicative aspects of the patient-
HCP relationship [30]. For this study, we omitted six
items, e.g., ‘The doctors are being interested in my pro-
blems;’ additionally, we included an item to measure
overall satisfaction. We chose the MPSS-24 because it
focuses on the HCPs’ competence. The scale will be
adopted for each subgroup (doctors, physicians, health-
care givers, therapists). In addition, patients also rated
their overall level of satisfaction with healthcare on a
10-point scale ranging from 1 (least satisfied) to 10
(most satisfied). In addition, we will control for several
aspects to limit the influence of unobserved variance.
We will control for functional diversity among health-
care teams by drawing on past research [2,31] that oper-
ationalizes this concept by addressing the tenure,
educational background, and functional background of
the team. In line with recommendations on how to
m e a s u r ed i v e r s i t y[ 3 2 ] ,w ew i l lm e a s u r et h em e n t i o n e d
variables using Blau’s index of heterogeneity, 1- ∑pi
2
[33]. In this formula, p represents the proportion of a
team in the respective diversity category, and i is the
number of different categories represented within a
team. Thus, an index of 0 indicates no diversity, while a
higher index score indicates that more diversity exists in
the measured variable among team members. Addition-
ally, we integrate the context of uncertainty as a second
control variable, which will be measured by a three-item
s c a l eo r i g i n a l l yu s e db yG l a d y set al., e.g., ‘The intensity
of the patients’ healthcare is unpredictable’ [34]. The
statistical analysis will explore the relationships between
the two predictor variables (knowledge sharing and
shared decision making) and both the dependent vari-
able of patient satisfaction and the mediating effect of
HCPs’ innovative behavior by controlling for functional
diversity within each team and environmental uncer-
tainty. The theoretical model will be tested using multi-
ple regression analysis and structural equation modeling.
In addition to phase II, we will evaluate the qualitative
data within phase III using MAXQDA in line with
recommendations for qualitative research and grounded
theory [26-28].
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Discussion
Patients with rare diseases regularly encounter serious
deficits in HCPs’ expertise and in treatment guidelines,
and this causes a high level of uncertainty and ambiguity
in routine healthcare processes. In this study, we argue
that the assembly of multidisciplinary healthcare teams
consisting of both routine and specialized HCPs is
required to generate individually tailored healthcare
concepts. Team diversity, i.e., the amount of multidisci-
plinarity and the level of qualification within a health-
care team, is considered to be a key contextual element.
Moreover, uncertainty and unpredictability create an
inability to predict accurately what the outcomes of
decisions might be [5,6]. This leads to an unstable and
uncontrolled situation for the patient [35,36]. In line
with these specific conditions, the proposed theory-
based approach will shed light on interaction processes
from an integrated perspective. After identifying the
main theoretical communication processes within
healthcare teams, they will be empirically tested. Our
study will investigate patients’ needs via qualitative data
and their satisfaction with the healthcare situation via
quantitative data. Moreover, HCPs’ innovative behavior
Hannemann-Weber et al. Implementation Science 2011, 6:40
http://www.implementationscience.com/content/6/1/40
Page 5 of 7will be investigated with special attention to their com-
munication activities within teams and with the patient.
This allows us to consider healthcare teams as a whole,
integrating the patients in particular. Thus, healthcare
teams include the whole multidisciplinary set of HCPs
including relatives and patients. Referring to our study
framework, healthcare teams with norms for shared
decision making and intensive knowledge sharing that
facilitate open communication among team members
may encourage individuals to innovate, which in turn
increases individual patient satisfaction. Hence, this
study will provide unique information on the most
important factors for improving the long-term care of
patients with rare diseases through the development of
individual innovative care concepts. We anticipate that
our results will significantlyc o n t r i b u t et or e s e a r c hb y
analyzing the role of knowledge sharing and shared
decision making within patient-centered healthcare
teams, and their impact on HCPs’ innovative attempts
to better meet patient’s needs and thereby improve
patient satisfaction. Supported by the qualitative results,
we aim to provide practical solutions: implementing and
subsequently institutionalizing central shared communi-
cations processes within healthcare teams including the
patient may be key in promoting patient-centered, indi-
vidualized innovative concepts for patients with rare dis-
eases. Our results will provide healthcare institutions
and HCPs with essential information for elaborating and
implementing individual care solutions through the
establishment of appropriate interaction and communi-
cation structures and processes. With respect to the lim-
itations of a single country study, we suggest that future
studies expand this German sample to an international
sample to generalize the results and to dissociate them
from country-specific confounding variables.
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